CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,561,956 | +12.1% | 94,034 | -8.4% | 0.00% | +33.3% |
| Q2 2023 | $2,284,430 | -10.1% | 102,671 | -12.4% | 0.00% | -25.0% |
| Q1 2023 | $2,539,743 | +5.6% | 117,255 | -1.0% | 0.00% | 0.0% |
| Q4 2022 | $2,404,338 | -19.4% | 118,382 | +1.8% | 0.00% | -20.0% |
| Q3 2022 | $2,982,000 | +5.7% | 116,284 | -1.9% | 0.01% | +25.0% |
| Q2 2022 | $2,820,000 | -4.2% | 118,588 | -9.3% | 0.00% | 0.0% |
| Q1 2022 | $2,945,000 | +2.2% | 130,783 | -10.1% | 0.00% | +33.3% |
| Q4 2021 | $2,882,000 | +2.5% | 145,537 | +1.9% | 0.00% | -25.0% |
| Q3 2021 | $2,812,000 | -4.1% | 142,885 | +7.2% | 0.00% | 0.0% |
| Q2 2021 | $2,931,000 | -16.0% | 133,235 | -9.2% | 0.00% | -20.0% |
| Q1 2021 | $3,491,000 | -9.3% | 146,740 | -0.3% | 0.01% | 0.0% |
| Q4 2020 | $3,850,000 | +52.0% | 147,182 | +1.1% | 0.01% | +25.0% |
| Q3 2020 | $2,533,000 | +3.5% | 145,511 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,447,000 | +41.4% | 145,511 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,730,000 | -3.0% | 145,511 | -1.3% | 0.00% | +33.3% |
| Q4 2019 | $1,784,000 | -15.4% | 147,420 | -1.2% | 0.00% | -25.0% |
| Q3 2019 | $2,109,000 | +27.0% | 149,187 | +0.2% | 0.00% | +33.3% |
| Q2 2019 | $1,660,000 | -6.2% | 148,921 | -1.2% | 0.00% | -25.0% |
| Q1 2019 | $1,769,000 | -13.4% | 150,654 | -1.5% | 0.00% | -20.0% |
| Q4 2018 | $2,043,000 | -2.5% | 152,887 | +2.3% | 0.01% | +25.0% |
| Q3 2018 | $2,096,000 | -10.8% | 149,497 | +0.0% | 0.00% | -20.0% |
| Q2 2018 | $2,350,000 | +2.9% | 149,492 | +7.7% | 0.01% | 0.0% |
| Q1 2018 | $2,284,000 | -12.0% | 138,820 | -3.4% | 0.01% | 0.0% |
| Q4 2017 | $2,595,000 | -7.8% | 143,687 | -1.5% | 0.01% | -16.7% |
| Q3 2017 | $2,816,000 | +47.8% | 145,926 | -9.6% | 0.01% | +50.0% |
| Q2 2017 | $1,905,000 | +18.1% | 161,438 | +9.7% | 0.00% | +33.3% |
| Q1 2017 | $1,613,000 | +44.3% | 147,138 | -4.4% | 0.00% | +50.0% |
| Q4 2016 | $1,118,000 | +8.9% | 153,938 | -2.6% | 0.00% | 0.0% |
| Q3 2016 | $1,027,000 | +20.1% | 158,038 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $855,000 | +39.5% | 156,638 | +19.5% | 0.00% | +100.0% |
| Q1 2016 | $613,000 | +7.4% | 131,064 | +14.2% | 0.00% | 0.0% |
| Q4 2015 | $571,000 | +34.7% | 114,746 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $424,000 | -37.6% | 112,640 | -0.4% | 0.00% | -50.0% |
| Q2 2015 | $679,000 | +23.2% | 113,040 | +14.8% | 0.00% | +100.0% |
| Q1 2015 | $551,000 | +86.8% | 98,465 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $295,000 | +12.2% | 98,465 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $263,000 | -3.7% | 98,044 | +0.7% | 0.00% | 0.0% |
| Q2 2014 | $273,000 | -34.7% | 97,385 | +1.6% | 0.00% | 0.0% |
| Q1 2014 | $418,000 | +35.3% | 95,885 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $309,000 | +103.3% | 95,885 | 0.0% | 0.00% | – |
| Q3 2013 | $152,000 | -5.0% | 95,885 | +3.4% | 0.00% | -100.0% |
| Q2 2013 | $160,000 | -6.4% | 92,750 | +8.6% | 0.00% | 0.0% |
| Q1 2013 | $171,000 | – | 85,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |